BIOMAT Database Logo BIOMAT Database Logo

Hyperthermic antiblastic perfusion for the treatment of soft tissue limb sarcoma. 1992

F Di Filippo, and D Giannarelli, and C Botti, and S Carlini, and F Cavaliere, and R Garinei, and M Schiratti, and V Casaldi, and M Tedesco, and R Cavaliere
Department of Surgical Oncology, Regina Elena National Cancer Institute, Rome, Italy.

Eighty patients with locally advanced, high grade soft tissue sarcoma of the extremities were studied prospectively in order to determine the efficacy of hyperthermic antiblastic perfusion (H.A.P.) as the first step of a combined multimodality therapy. All of the patients have been evaluated in terms of functional results, loco-regional control and survival according to the different treatment schedules adopted. The first clinical trial employed H.A.P., followed by surgery alone. Because the results obtained were unsatisfactory, the protocol was modified to include a continuous intra-arterial (i.a.) infusion of doxorubicin (dx) or radiotherapy before surgery. The best results have been obtained with the radiotherapy-including protocol showing a conservative surgery rate of 100% and a 94% rate of loco-regional control. The disease-free, distant disease-free and overall survival rates were 68%, 75% and 70%, respectively. The importance of the treatment protocol has been confirmed in a multivariate analysis which demonstrated that the treatment protocol adopted is one of the prognostic factors with an independent value (p = 0.06).

UI MeSH Term Description Entries
D006979 Hyperthermia, Induced Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs. Fever Therapy,Hyperthermia, Local,Hyperthermia, Therapeutic,Thermotherapy,Induced Hyperthermia,Therapeutic Hyperthermia,Therapy, Fever,Local Hyperthermia
D010478 Chemotherapy, Cancer, Regional Perfusion Neoplasm drug therapy involving an extracorporeal circuit with temporary exclusion of the tumor-bearing area from the general circulation during which high concentrations of the drug are perfused to the isolated part. Cancer Chemotherapy, Regional Perfusion,Perfusion Cancer Chemotherapy, Regional,Regional Perfusion Antineoplastic Chemotherapy,Isolation Perfusion Cancer Chemotherapy,Regional Perfusion Cancer Chemotherapy
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005121 Extremities The farthest or outermost projections of the body, such as the HAND and FOOT. Limbs,Extremity,Limb
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012509 Sarcoma A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant. Sarcoma, Epithelioid,Sarcoma, Soft Tissue,Sarcoma, Spindle Cell,Epithelioid Sarcoma,Epithelioid Sarcomas,Sarcomas,Sarcomas, Epithelioid,Sarcomas, Soft Tissue,Sarcomas, Spindle Cell,Soft Tissue Sarcoma,Soft Tissue Sarcomas,Spindle Cell Sarcoma,Spindle Cell Sarcomas
D012983 Soft Tissue Neoplasms Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc. Neoplasm, Soft Tissue,Neoplasms, Soft Tissue,Soft Tissue Neoplasm
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

F Di Filippo, and D Giannarelli, and C Botti, and S Carlini, and F Cavaliere, and R Garinei, and M Schiratti, and V Casaldi, and M Tedesco, and R Cavaliere
Soft tissue limb sarcomas: Italian clinical trials with hyperthermic antiblastic perfusion.
November 1999, Cancer,
F Di Filippo, and D Giannarelli, and C Botti, and S Carlini, and F Cavaliere, and R Garinei, and M Schiratti, and V Casaldi, and M Tedesco, and R Cavaliere
Hyperthermic limb perfusion for malignant melanoma and soft tissue sarcoma.
August 1990, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
F Di Filippo, and D Giannarelli, and C Botti, and S Carlini, and F Cavaliere, and R Garinei, and M Schiratti, and V Casaldi, and M Tedesco, and R Cavaliere
[Doxorubicin in antiblastic hyperthermic perfusion in the treatment of advanced soft-tissue sarcoma of the limbs].
January 2005, I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.],
F Di Filippo, and D Giannarelli, and C Botti, and S Carlini, and F Cavaliere, and R Garinei, and M Schiratti, and V Casaldi, and M Tedesco, and R Cavaliere
Hyperthermic isolated limb perfusion for the treatment of soft tissue sarcomas.
January 1998, Seminars in surgical oncology,
F Di Filippo, and D Giannarelli, and C Botti, and S Carlini, and F Cavaliere, and R Garinei, and M Schiratti, and V Casaldi, and M Tedesco, and R Cavaliere
Impact of hyperthermic isolated limb perfusion on tumour oxygenation in soft tissue sarcoma.
January 2012, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group,
F Di Filippo, and D Giannarelli, and C Botti, and S Carlini, and F Cavaliere, and R Garinei, and M Schiratti, and V Casaldi, and M Tedesco, and R Cavaliere
Conventional isolated hyperthermic antiblastic perfusion in the treatment of recurrent limb melanoma.
January 1996, Anticancer research,
F Di Filippo, and D Giannarelli, and C Botti, and S Carlini, and F Cavaliere, and R Garinei, and M Schiratti, and V Casaldi, and M Tedesco, and R Cavaliere
Quality of life after hyperthermic isolated limb perfusion for locally advanced extremity soft tissue sarcoma.
June 2006, Annals of surgical oncology,
F Di Filippo, and D Giannarelli, and C Botti, and S Carlini, and F Cavaliere, and R Garinei, and M Schiratti, and V Casaldi, and M Tedesco, and R Cavaliere
[Isolated hyperthermic extremity perfusion in soft tissue sarcoma].
June 1997, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
F Di Filippo, and D Giannarelli, and C Botti, and S Carlini, and F Cavaliere, and R Garinei, and M Schiratti, and V Casaldi, and M Tedesco, and R Cavaliere
FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma.
June 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
F Di Filippo, and D Giannarelli, and C Botti, and S Carlini, and F Cavaliere, and R Garinei, and M Schiratti, and V Casaldi, and M Tedesco, and R Cavaliere
Hyperthermic isolated limb perfusion in locally advanced limb soft tissue sarcoma: A 24-year single-centre experience.
January 2016, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group,
Copied contents to your clipboard!